Cardiac magnetic resonance angiography (CMRA)
Cardiac magnetic resonance angiography (CMRA) is an imaging modality that provides a mechanism to assess cardiac or vascular anatomy, function, perfusion, and tissue characteristics in a highly reproducible manner, during a single examination. CMRA can also be used to determine coronary artery patency in adults with coronary artery disease (CAD), and as a diagnostic modality for patients with suspected anomalous coronary anatomy.
Status: Decision completed
Why is CMRA being reviewed?
There have been a number of CMRA technological advances in the past decade; however, its accuracy and clinical utility for diagnosis in routine clinical practice are unclear. This topic was selected because of medium-level concerns about the safety and efficacy of CMRA and high-level concern about costs. The objective of the health technology assessment (HTA) is to evaluate the diagnostic validity (i.e., accuracy), clinical utility (i.e., effectiveness), safety, and cost-effectiveness of CMRA in adults or children with known or suspected coronary vessel anomalies or congenital heart disease.
Primary Criteria Ranking
- Safety = Medium
- Efficacy = High
- Cost = High
Documentation
| Type | Materials |
|---|---|
| Assessment (2021) |
Assessment timeline
- Draft key questions published: March 15, 2021
- Public comment period: March 16 to March 30, 2021
- Final key questions published: April 12, 2021
- Draft report published: September 7, 2021
- Public comment period: September 7 to October 6, 2021
- Final report published: October 20, 2021
- HTCC public meeting: November 19, 2021